Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

In this report, we present a case study of how pharmacogenomics and pharmacometabolomics can be useful to characterize safety and pharmacokinetic profiles in early phase new drug development clinical trials. During conducting a first-in-human trial for a new molecular entity, we were able to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jaeseong, Yi, Sojeong, Gu, Namyi, Shin, Dongseong, Yu, Kyung-Sang, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Gastrointestinal Intervention 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187817/
https://www.ncbi.nlm.nih.gov/pubmed/30309203
http://dx.doi.org/10.5808/GI.2018.16.3.52

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187817/
https://www.ncbi.nlm.nih.gov/pubmed/30309203
http://dx.doi.org/10.5808/GI.2018.16.3.52

Ejemplares similares